The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jennifer A. Quinn

Dept. of Medicine

Division of Neurology

Duke University Medical Center

Durham

USA

[email]@mc.duke.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Dept. of Medicine, Division of Neurology, Duke University Medical Center, Durham, USA. 2002 - 2009

References

  1. Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma. Quinn, J.A., Jiang, S.X., Reardon, D.A., Desjardins, A., Vredenburgh, J.J., Rich, J.N., Gururangan, S., Friedman, A.H., Bigner, D.D., Sampson, J.H., McLendon, R.E., Herndon, J.E., Walker, A., Friedman, H.S. Neuro-oncology (2009) [Pubmed]
  2. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. Quinn, J.A., Desjardins, A., Weingart, J., Brem, H., Dolan, M.E., Delaney, S.M., Vredenburgh, J., Rich, J., Friedman, A.H., Reardon, D.A., Sampson, J.H., Pegg, A.E., Moschel, R.C., Birch, R., McLendon, R.E., Provenzale, J.M., Gururangan, S., Dancey, J.E., Maxwell, J., Tourt-Uhlig, S., Herndon, J.E., Bigner, D.D., Friedman, H.S. J. Clin. Oncol. (2005) [Pubmed]
  3. Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma. Quinn, J.A., Reardon, D.A., Friedman, A.H., Rich, J.N., Sampson, J.H., Vredenburgh, J., Gururangan, S., Provenzale, J.M., Walker, A., Schweitzer, H., Bigner, D.D., Tourt-Uhlig, S., Herndon, J.E., Affronti, M.L., Jackson, S., Allen, D., Ziegler, K., Bohlin, C., Lentz, C., Friedman, H.S. Neuro-oncology (2004) [Pubmed]
  4. Phase II trial of temozolomide in patients with progressive low-grade glioma. Quinn, J.A., Reardon, D.A., Friedman, A.H., Rich, J.N., Sampson, J.H., Provenzale, J.M., McLendon, R.E., Gururangan, S., Bigner, D.D., Herndon, J.E., Avgeropoulos, N., Finlay, J., Tourt-Uhlig, S., Affronti, M.L., Evans, B., Stafford-Fox, V., Zaknoen, S., Friedman, H.S. J. Clin. Oncol. (2003) [Pubmed]
  5. Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. Quinn, J.A., Pluda, J., Dolan, M.E., Delaney, S., Kaplan, R., Rich, J.N., Friedman, A.H., Reardon, D.A., Sampson, J.H., Colvin, O.M., Haglund, M.M., Pegg, A.E., Moschel, R.C., McLendon, R.E., Provenzale, J.M., Gururangan, S., Tourt-Uhlig, S., Herndon, J.E., Bigner, D.D., Friedman, H.S. J. Clin. Oncol. (2002) [Pubmed]
 
WikiGenes - Universities